https://www.selleckchem.com/pr....oducts/zunsemetinib.
Heterogeneity was evaluated and sources were investigated using subgroup and sensitivity analysis. Significant differences were found in the overall proportions of high TB incidence migrants and non-migrants for MDR cases, clustered cases, HIV coinfections and successful treatment, as well as a significant difference in the OR among MDR cases (3.91). This review has demonstrated significant differences in key epidemiological indicators between high TB incidence migrants and non-migrants, indicating policy implications. This review
Like
Comment
Share
